Endometriosis
Open accessThe DOI matches its Crossref record; 208 of the 214 references it cites were found in a registry or an index.
Abstract
Pelvic endometriosis is a complex syndrome characterized by an estrogen-dependent chronic inflammatory process that affects primarily pelvic tissues, including the ovaries. It is caused when shed endometrial tissue travels retrograde into the lower abdominal cavity. Endometriosis is the most common cause of chronic pelvic pain in women and is associated with infertility. The underlying pathologic mechanisms in the intracavitary endometrium and extrauterine endometriotic tissue involve defectively programmed endometrial mesenchymal progenitor/stem cells. Although endometriotic stromal cells, which compose the bulk of endometriotic lesions, do not carry somatic mutations, they demonstrate specific epigenetic abnormalities that alter expression of key transcription factors. For example, GATA-binding factor-6 overexpression transforms an endometrial stromal cell to an endometriotic phenotype, and steroidogenic factor-1 overexpression causes excessive production of estrogen, which drives inflammation via pathologically high levels of estrogen receptor-β. Progesterone receptor deficiency causes progesterone resistance. Populations of endometrial and endometriotic epithelial cells also harbor multiple cancer driver mutations, such as KRAS, which may be associated with the establishment of pelvic endometriosis or ovarian cancer. It is not known how interactions between epigenomically defective stromal cells and the mutated genes in epithelial cells contribute to the pathogenesis of endometriosis. Endometriosis-associated pelvic pain is managed by suppression of ovulatory menses and estrogen production, cyclooxygenase inhibitors, and surgical removal of pelvic lesions, and in vitro fertilization is frequently used to overcome infertility. Although novel targeted treatments are becoming available, as endometriosis pathophysiology is better understood, preventive approaches such as long-term ovulation suppression may play a critical role in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Since P4 signaling is required to counteract E2-induced proliferation and to promote decidualization [55], the loss of P4-responsiveness leads to both an increased growth of endometriotic lesions and to a non-receptive endometrium [33, 56].”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“During the follicular phase, estrogen acts on eutopic endometrium through the estrogen receptor (ER) to increase transcription and protein levels of the progesterone receptor (PR), especially the PR-B isoform.”
From Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review (2021) · cites this paper as [15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“in endometriotic implants, ERα is reduced but ERβ activity is upregulated, leading to complete loss of PR-B, which is then unable to induce 17β-HSD2.”
From Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review (2021) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Clear data show that endometriotic tissue expresses the entire set of steroidogenic genes, including aromatase, allowing to local de-novo estradiol (E2) production. [33]”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [33]
The cited source says what the claim attributes to it.
In the citing paper
“PR resistance in endometriotic cells results in CRABP2 deficiency, thereby favoring survival, development and persistence of endometriotic implants [15,16].”
From Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review (2021) · cites this paper as [15]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
Funk, C. D. (2001) · Science · doi:10.1126/science.294.5548.1871 · Cited by 3,817
Giudice, L. C., & Kao, L. C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17403-5 · Cited by 3,166
Sampson, J. A. (1927) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30003-x · Cited by 2,334
Endometriosis: pathogenesis and treatment
Vercellini, P., Viganò, P., Somigliana, E., & Fedele, L. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.255 · Cited by 1,940
Giudice, L. C. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp1000274 · Cited by 1,924
Bulun, S. E. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804690 · Cited by 1,772
Self-citationARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Wiegand, K. C., Shah, S. P., Al-Agha, O. M., Zhao, Y., Tse, K., Zeng, T., Senz, J., McConechy, M. K., Anglesio, M. S., Kalloger, S. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008433 · Cited by 1,712
Eskenazi, B., & Warner, M. L. (1997) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70302-8 · Cited by 1,617
(1927) · PubMed Central · Cited by 1,008
Immunobiology of endometriosis
Lebovic, D. I., Mueller, M. D., & Taylor, R. N. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01630-7 · Cited by 857
Research works printed but not linked: 3
- Evers J, Dunselman G, Land J, Bouckaert P, Van Der Linden P. Management of recurrent endometriosis. In: Coutinho EM, Spinola P, Hanson de Moura L, eds. Progress in the Management of Endometriosis. London, UK: Parthenon Publishing Group; 1995:291–297. [Google Scholar]
- Bulun SE. Endometriosis. In: Strauss J, Barbieri R, eds. Yen & Jaffe’s Reproductive Endocrinology. 8th ed. Philadelphia, PA: Elsevier; 2019:609–642. [Google Scholar]
- Bulun S, Adashi E. The physiology and pathology of the female reproductive axis. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR, eds. Williams Textbook of Endocrinology, 10th ed. Philadelphia, PA: Elsevier Health Sciences; 2003:587–663. [Google Scholar]
Cited by
Endometriosis is a chronic systemic disease: Clinical challenges and novel innovations
Taylor, H. S., Kotlyar, A. M., & Flores, V. A. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00389-5 · Cited by 1,425
Progesterone and Estrogen Signaling in the Endometrium: What Goes Wrong in Endometriosis?
Marquardt, R. M., Kim, T. H., Shin, J.-H., & Jeong, J.-W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153822 · Cited by 491
“The prevalence of endometriosis is di ffi cult to establish with certainty due to the requirement of surgical visualization of lesions for definitive diagnosis, but it is generally accepted that it occurs in about 1 in 10 women of reproductive age [8,9,120].”
InfluentialHormonal treatments for endometriosis: The endocrine background
Vannuccini, S., Clemenza, S., Rossi, M., & Petraglia, F. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09666-w · Cited by 336
Estrogen Receptors and Endometriosis
Chantalat, E., Valera, M.-C., Vaysse, C., Noirrit, E., Rusidze, M., Weyl, A., Vergriete, K., Buscail, E., Lluel, P., Fontaine, C., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082815 · Cited by 297
Estrogen-Receptor Expression and Function in Female Reproductive Disease
Tang, Z.-R., Zhang, R., Lian, Z.-X., Deng, S.-L., & Yu, K. (2019) · Cells · doi:10.3390/cells8101123 · Cited by 274
Pathogenesis Based Diagnosis and Treatment of Endometriosis
Koninckx, P. R., Fernandes, R., Ussia, A., Schindler, L., Wattiez, A., Al-Suwaidi, S., Amro, B., Al-Maamari, B., Hakim, Z., & Tahlak, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.745548 · Cited by 273
Endometriosis and adenomyosis: shared pathophysiology
Bulun, S. E., Yildiz, S., Adli, M., Chakravarti, D., Parker, J. B., Milad, M., Yang, L., Chaudhari, A., Tsai, S., Wei, J. J., et al. (2023) · Fertility and Sterility · doi:10.1016/j.fertnstert.2023.03.006 · Cited by 216
Self-citationAdenomyosis pathogenesis: insights from next-generation sequencing
Bulun, S. E., Yildiz, S., Adli, M., & Wei, J.-J. (2021) · Human Reproduction Update · doi:10.1093/humupd/dmab017 · Cited by 202
Self-citationOrisaka, M., Mizutani, T., Miyazaki, Y., Shirafuji, A., Tamamura, C., Fujita, M., Tsuyoshi, H., & Yoshida, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1324429 · Cited by 199
“It is a disease characterized by the growth of endometrial tissue outside the uterine cavity and estrogen-dependent chronic in fl ammation, primarily affecting pelvic tissues, including the ovary (i.e., endometrioma) (85).”
BackgroundRegulation of Inflammation Pathways and Inflammasome by Sex Steroid Hormones in Endometriosis
García-Gómez, E., Vázquez-Martínez, E. R., Reyes-Mayoral, C., Cruz-Orozco, O. P., Camacho-Arroyo, I., & Cerbón, M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00935 · Cited by 195
Donnez, J., & Dolmans, M.-M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10051085 · Cited by 182
Progesterone Actions and Resistance in Gynecological Disorders
MacLean, J. A., & Hayashi, K. (2022) · Cells · doi:10.3390/cells11040647 · Cited by 176
Muraoka, A., Suzuki, M., Hamaguchi, T., Watanabe, S., Iijima, K., Murofushi, Y., Shinjo, K., Osuka, S., Hariyama, Y., Ito, M., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.add1531 · Cited by 172
Szczuko, M., Kikut, J., Komorniak, N., Bilicki, J., Celewicz, Z., & Ziętek, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249628 · Cited by 172
Progesterone Resistance in Endometriosis: Current Evidence and Putative Mechanisms
Zhang, P., & Wang, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24086992 · Cited by 160
Endometriosis: A Disease with Few Direct Treatment Options
França, P. R. D. C., Lontra, A. C. P., & Fernandes, P. D. (2022) · Molecules · doi:10.3390/molecules27134034 · Cited by 171
Targeting Oxidative Stress Involved in Endometriosis and Its Pain
Clower, L., Fleshman, T., Geldenhuys, W. J., & Santanam, N. (2022) · Biomolecules · doi:10.3390/biom12081055 · Cited by 145
Selective Progesterone Receptor Modulators—Mechanisms and Therapeutic Utility
Islam, M. S., Afrin, S., Jones, S. I., & Segars, J. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa012 · Cited by 143
Epigenetic Dysregulation in Endometriosis: Implications for Pathophysiology and Therapeutics
Marquardt, R. M., Tran, D. N., Lessey, B. A., Rahman, M. S., & Jeong, J. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad020 · Cited by 147
Donnez, J., Taylor, H. S., Taylor, R. N., Akin, M. D., Tatarchuk, T. F., Wilk, K., Gotteland, J.-P., Lecomte, V., & Bestel, E. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.02.114 · Cited by 124
Recurrent implantation failure: reality or a statistical mirage?
Pirtea, P., Cedars, M. I., Devine, K., Ata, B., Franasiak, J. M., Racowsky, C., Toner, J., Scott, R. T., de Ziegler, D., & Barnhart, K. T. (2023) · Fertility and Sterility · doi:10.1016/j.fertnstert.2023.02.014 · Cited by 131
New Understanding of Diagnosis, Treatment and Prevention of Endometriosis
Amro, B., Aristondo, M. E. R., Al-Suwaidi, S., Al-Maamari, B., Hakim, Z. T., Tahlak, M., Wattiez, A., & Koninckx, P. R. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19116725 · Cited by 136
Molecular Basis of Endometriosis and Endometrial Cancer: Current Knowledge and Future Perspectives
Terzić, M., Aimagambetova, G. N., Kunz, J., Bapayeva, G., Aitbayeva, B., Terzic, S., & Laganà, A. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179274 · Cited by 126
Giudice, L. C., Oskotsky, T., Falako, S., Opoku‐Anane, J., & Sirota, M. (2023) · The FASEB Journal · doi:10.1096/fj.202300907 · Cited by 130
Melatonin Promotes Uterine and Placental Health: Potential Molecular Mechanisms
Chuffa, L. G. D. A., Lupi, L. A., Cucielo, M. S., Silveira, H. S., Reiter, R. J., & Seiva, F. R. F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010300 · Cited by 116
Ovarian hormones-autophagy-immunity axis in menstruation and endometriosis
Shen, H., Zhang, T., Yang, H., Lai, Z., Zhou, W., Mei, J., Shi, J., Zhu, R., Xu, F., Li, D., et al. (2021) · Theranostics · doi:10.7150/thno.55241 · Cited by 116
Gou, Y., Wang, H., Wang, T., Wang, H., Wang, B., Jiao, N., Yu, Y., Cao, Y., Wang, H., & Zhang, Z. (2022) · Immunology · doi:10.1111/imm.13574 · Cited by 110
Genetic, Epigenetic, and Steroidogenic Modulation Mechanisms in Endometriosis
Zubrzycka, A., Zubrzycki, M., Perdas, E., & Zubrzycka, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051309 · Cited by 92
A Lifelong Impact on Endometriosis: Pathophysiology and Pharmacological Treatment
Chen, L.-H., Lo, W.-C., Huang, H.-Y., & Wu, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087503 · Cited by 111
Pathogenesis of Endometriosis and Endometriosis-Associated Cancers
Adilbayeva, A., & Kunz, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147624 · Cited by 104
“Numerous models have been proposed to explain how endometriosis is initiated and how endometriotic tissue can grow throughout the abdominal cavity and disperse to extrapelvic locations [2–4].”
BackgroundQuality of life in women with endometriosis: a cross-sectional survey
Bień, A., Rzońca, E., Zarajczyk, M., Wilkosz, K., Wdowiak, A., & Iwanowicz-Palus, G. (2020) · Quality of Life Research · doi:10.1007/s11136-020-02515-4 · Cited by 110
Endocrine disrupting chemicals and reproductive disorders in women, men, and animal models
Laws, M. J., Neff, A. M., Brehm, E., Warner, G. R., & Flaws, J. A. (2021) · Advances in pharmacology · doi:10.1016/bs.apha.2021.03.008 · Cited by 103
New Insights in Pathogenesis of Endometriosis
Signorile, P. G., Viceconte, R., & Baldi, A. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.879015 · Cited by 110
Cracking the enigma of adenomyosis: an update on its pathogenesis and pathophysiology
Guo, S. (2022) · Reproduction · doi:10.1530/rep-22-0224 · Cited by 100
Endometriosis and polycystic ovary syndrome are diametric disorders
Dinsdale, N. L., & Crespi, B. J. (2021) · Evolutionary Applications · doi:10.1111/eva.13244 · Cited by 90
“Endometriosis is described as an estrogen- dependent, chronic inflammatory disease (Bulun et al., 2019).”
BackgroundInfluentialNK Cells as Potential Targets for Immunotherapy in Endometriosis
Ścieżyńska, A., Komorowski, M., Soszyńska, M., & Malejczyk, J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091468 · Cited by 92
Strategies for modelling endometrial diseases
Murphy, A. R., Campo, H., & Kim, J. J. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00725-z · Cited by 89
Exploring diagnostic m6A regulators in endometriosis
Jiang, L., Zhang, M., Wu, J., Wang, S., Xiang, Y., Yi, M., Zhang, X., & Fang, X. (2020) · Aging · doi:10.18632/aging.202163 · Cited by 86
Guo, X., Xu, X., Li, T., Yu, Q., Wang, J., Chen, Y., Ding, S., Zhu, L., Zou, G., & Zhang, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.749979 · Cited by 88
Wu, X., Chen, J., Zhou, H., Wu, Y., Lin, F., Shi, J., Wu, H.-Z., Xiao, H.-Q., & Wang, W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.671201 · Cited by 89
Gut dysbiosis-derived β-glucuronidase promotes the development of endometriosis
Wei, Y., Tan, H., Yang, R., Yang, F., Liu, D., Huang, B., Ouyang, L., Lei, S., Wang, Z., Jiang, S., et al. (2023) · Fertility and Sterility · doi:10.1016/j.fertnstert.2023.03.032 · Cited by 84
Gabriel, M., Fey, V., Heinosalo, T., Adhikari, P. R., Rytkönen, K. T., Komulainen, T., Huhtinen, K., Laajala, T. D., Siitari, H., Virkki, A., et al. (2020) · Scientific Data · doi:10.1038/s41597-020-00623-x · Cited by 84
Endometriosis-Related Chronic Pelvic Pain
Song, S. Y., Jung, Y. W., Shin, W., Park, M., Lee, G. W., Jeong, S., An, S., Kim, K.-M., Ko, Y. B., Lee, K. H., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11102868 · Cited by 97
Pathogenesis of Human Adenomyosis: Current Understanding and Its Association with Infertility
Khan, K. N., Fujishita, A., & Mori, T. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11144057 · Cited by 82
Environmental Endocrine Disruptors and Endometriosis
Rumph, J. T., Stephens, V. R., Archibong, A. E., Osteen, K. G., & Bruner‐Tran, K. L. (2020) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-030-51856-1_4 · Cited by 80
“Furthermore, the majority of women with endometriosis exhibit some degree of endometrial progesterone resistance, which contributes to subfertility and pregnancy loss (Bruner-Tran et al. 2002, 2010; Yilmaz and Bulun 2019).”
BackgroundAndrogens, oestrogens and endometrium: a fine balance between perfection and pathology
Gibson, D. A., Simitsidellis, I., Collins, F., & Saunders, P. T. K. (2020) · Journal of Endocrinology · doi:10.1530/joe-20-0106 · Cited by 76
The role of mitogen‐activated protein kinase signaling pathway in endometriosis
Bora, G., & Yaba, A. (2021) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.14710 · Cited by 79
Li, X., Xiong, W., Long, X., Dai, X., Peng, Y., Xu, Y., Zhang, Z., Zhang, L., & Liu, Y. (2021) · Biology of Reproduction · doi:10.1093/biolre/ioab152 · Cited by 77
Cano-Herrera, G., Nehmad, S. S., Gascón, J. R. D. C., Vionet, A. M., van Tienhoven, X. A., Martínez, M. F. O., Álvarez, M. M., Rivero, M. X. V., Torres, M. F. L., Valverde, M. J. B., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12071476 · Cited by 85
“This condition affects 5–10% of women of reproductive age worldwide and constitutes the most common cause of pelvic pain in women [1,3].”
Wu, J., Huang, H., Huang, W. J., Wang, L., Xia, X., & Fang, X. (2020) · Epigenomics · doi:10.2217/epi-2020-0084 · Cited by 74
Giacomini, E., Minetto, S., Piani, L. L., Pagliardini, L., Somigliana, E., & Viganò, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22169033 · Cited by 75
Endometriosis and the Fallopian Tubes: Theories of Origin and Clinical Implications
Hill, C. J., Fakhreldin, M., Maclean, A., Dobson, L., Nancarrow, L., Bradfield, A., Choi, F., Daley, D., Tempest, N., & Hapangama, D. K. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061905 · Cited by 78
Maulitz, L., Stickeler, E., Stickel, S., Habel, U., Tchaikovski, S. N., & Chechko, N. (2022) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2022.100988 · Cited by 71
Hu, X., Wu, H., Yong, X., Wang, Y., Yang, S., Fan, D., Xiao, Y., Che, L., Shi, K., Li, K., et al. (2023) · MedComm · doi:10.1002/mco2.425 · Cited by 79
Immunotherapy: A promising novel endometriosis therapy
Li, W., Lin, A., Qi, L., Lv, X., Yan, S., Xue, J., & Mu, N. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1128301 · Cited by 81
Wang, X., Wang, J., Zhao, X., Wu, H., Li, J., Cheng, Y. F., Guo, Q., Cao, X., Liang, T., Sun, L., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04209-0 · Cited by 67
Adenomyosis and Infertility: A Literature Review
Pados, G., Gordts, S., Sorrentino, F., Nisolle, M., Nappi, L., & Daniilidis, A. (2023) · Medicina · doi:10.3390/medicina59091551 · Cited by 76
“Excessive levels of local estradiol in adenomyosis may be given to estrogen excess and HSD17 β 2 deficiency [22].”
BackgroundStigma and mental health in endometriosis
Kocas, H. D., Rubin, L. R., & Lobel, M. (2023) · European Journal of Obstetrics & Gynecology and Reproductive Biology X · doi:10.1016/j.eurox.2023.100228 · Cited by 73
Female reproductive disease, endometriosis: From inflammation to infertility
Park, W., Lim, W., Kim, M., Jang, H., Park, S. J., Song, G., & Park, S. (2024) · Molecules and Cells · doi:10.1016/j.mocell.2024.100164 · Cited by 67
“Inflammation is a central pathophysiological mechanism of endometriosis, playing a role in pain, lesion implantation, fibrosis, and angiogenesis (Bulun et al., 2019).”
Neurogenic Inflammation in the Context of Endometriosis—What Do We Know?
Velho, R. V., Taube, E., Sehouli, J., & Mechsner, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313102 · Cited by 62
Jiang, H., Zhang, X., Wu, Y., Zhang, B., Wei, J., Li, J., Huang, Y., Chen, L., & He, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.944683 · Cited by 65
Self-citationDonnez, J., Becker, C. M., Taylor, H. S., Carmona, F., Donnez, O., Horne, A. W., Paszkowski, M., Petraglia, F., Renner, S. P., Patel, A., et al. (2024) · Human Reproduction · doi:10.1093/humrep/deae076 · Cited by 68
“According to Flores et al. (2018), Yilmaz and Bulun (2019), Bulun et al. (2019, 2023), Reis et al. (2020), and Donnez (2021), the inability of endometriotic stromal cells to produce progesterone-induced paracrine factors could stem from a deficiency in progesterone receptor B (PR-B).”
Endometriosis research in the -omics era
Goulielmos, G. N., Matalliotakis, M., Matalliotaki, C., Eliopoulos, E., Matalliotakis, I., & Zervou, M. I. (2020) · Gene · doi:10.1016/j.gene.2020.144545 · Cited by 62
Advances in the medical management of bowel endometriosis
Vercellini, P., Sergenti, G., Buggio, L., Frattaruolo, M. P., Dridi, D., & Berlanda, N. (2021) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2020.06.004 · Cited by 51
The known, the unknown and the future of the pathophysiology of endometriosis
Ochoa Bernal, M. A., & Fazleabas, A. T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115815 · Cited by 59
“Endometriotic tissue can also express a complete set of steroidogenic genes, including aromatase, allowing local conversion of cholesterol to estradiol [50,51].”
BackgroundDonnez, J., & Dolmans, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111342 · Cited by 61
Shu, Z., Wang, A., Xu, W., Hu, L., Sun, J., Wang, X., & Wang, X. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166602 · Cited by 60
Endometriosis Treatment: Role of Natural Polyphenols as Anti-Inflammatory Agents
Tassinari, V., Smeriglio, A., Stillittano, V., Trombetta, D., Zilli, R., Tassinari, R., Maranghi, F., Frank, G., Marcoccia, D., & Renzo, L. D. (2023) · Nutrients · doi:10.3390/nu15132967 · Cited by 61
Yang, F. Y., Wu, Y., Hockey, R., Doust, J. A., Mishra, G. D., Montgomery, G. W., & Mortlock, S. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101250 · Cited by 59
Liu, S., Li, X., Gu, Z., Wu, J., Jia, S., Shi, J., Dai, Y. L., Wu, Y., Yan, H., Zhang, J., et al. (2025) · Cell Genomics · doi:10.1016/j.xgen.2024.100737 · Cited by 65
“2,11,20,64,65 Our findings on macrophage distribution in endometriomas are consistent with recent work by Tan et al. 15 They found that tissue-resident macrophages, which express genes associated with immune tolerance and tissue remodeling, were enriched in endometriotic lesions.”
Self-citationRole of SIRT1 and Progesterone Resistance in Normal and Abnormal Endometrium
Kim, T. H., Young, S. L., Sasaki, T., Deaton, J. L., Schammel, D. P., Palomino, W. A., Jeong, J., & Lessey, B. A. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab753 · Cited by 55
Lu, F., Wei, J., Zhong, Y., Feng, Y., Ma, B., Xiong, Y., Wei, K., Tan, B., & Chen, T. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.831115 · Cited by 61
Self-citationGołąbek-Grenda, A., & Olejnik, A. M. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110375 · Cited by 59
Delenko, J., Xue, X., Chatterjee, P. K., Hyman, N., Shih, A., Adelson, R. P., Tepeš, P. Š., Gregersen, P. K., & Metz, C. N. (2024) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-024-01265-z · Cited by 55
The Estrogen–Immune Interface in Endometriosis
Greygoose, E., Metharom, P., Kula, H., Seckin, T. K., Seckin, T. A., Ayhan, A., & Yu, Y. (2025) · Cells · doi:10.3390/cells14010058 · Cited by 60
“A unique known challenge in endometriosis, P4 resistance, stems from the deficiency of P4 in the stromal cells of endometriotic tissue, complicating the hormonal and immune interplay characteristic of the condition [63,64].”
The evolutionary biology of endometriosis
Dinsdale, N., Nepomnaschy, P., & Crespi, B. (2021) · Evolution, Medicine, and Public Health · doi:10.1093/emph/eoab008 · Cited by 53
Tofacitinib alters STAT3 signaling and leads to endometriosis lesion regression
Kotlyar, A. M., Mamillapalli, R., Flores, V. A., & Taylor, H. S. (2021) · Molecular Human Reproduction · doi:10.1093/molehr/gaab016 · Cited by 53
BCL6 , a key oncogene, in the placenta, pre-eclampsia and endometriosis
Louwen, F., Kreis, N., Ritter, A., Friemel, A., Solbach, C., & Yuan, J. (2022) · Human Reproduction Update · doi:10.1093/humupd/dmac027 · Cited by 53
“Additionally, BM-MSCs may improve endometrial regeneration through secreting paracrine factors to stimulate resident endometrial .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. . stem cells (Yilmaz and Bulun, 2019).”
BackgroundVercellini, P., Bandini, V., Viganò, P., Stefano, G. D., Merli, C. E. M., & Somigliana, E. (2023) · Human Reproduction · doi:10.1093/humrep/dead229 · Cited by 54
“…effect on health-related quality of life, psychological mood, sexual function, inter-personal and social relationships, working capacity, use of healthcare resources, and overall societal costs (Zondervan et al. , 2018, 2020; Bulun et al. , 2019; Taylor et al. , 2021; Horne and Missmer, 2022).”
InfluentialAldo-keto reductase 1C3—Assessment as a new target for the treatment of endometriosis
Rižner, T. L., & Penning, T. M. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104446 · Cited by 55
Integrated Bioinformatic Analysis of DNA Methylation and Immune Infiltration in Endometrial Cancer
Dai, F., Wu, J., Deng, Z., Li, H., Tan, W., Yuan, M., Yang, D., Liu, S., Zheng, Y., Hu, M. S., et al. (2022) · BioMed Research International · doi:10.1155/2022/5119411 · Cited by 53
“However, it is challenging to treat patients with advanced endometrial cancer, which often has a poor prognosis [27].”
Self-citationA Revised Stem Cell Theory for the Pathogenesis of Endometriosis
Maruyama, T. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020216 · Cited by 58
Effectiveness of NLRP3 Inhibitor as a Non-Hormonal Treatment for ovarian endometriosis
Murakami, M., Osuka, S., Muraoka, A., Hayashi, S., Bayasula, Kasahara, Y., Sonehara, R., Hariyama, Y., Shinjo, K., Tanaka, H., et al. (2022) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-022-00924-3 · Cited by 53
Yıldız, Ş., Kinali, M., Wei, J., Milad, M. P., Yin, P., Adli, M., & Bulun, S. E. (2023) · Fertility and Sterility · doi:10.1016/j.fertnstert.2023.01.041 · Cited by 52
Self-citationVercellini, P., Bandini, V., Viganò, P., Ambruoso, D., Cetera, G. E., & Somigliana, E. (2023) · Human Reproduction · doi:10.1093/humrep/dead206 · Cited by 53
Epigenetic Factors in Eutopic Endometrium in Women with Endometriosis and Infertility
Adamczyk, M., Wender-Ożegowska, E., & Kędzia, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073804 · Cited by 54
Xie, M., Qing, X., Huang, H., Zhang, L., Tu, Q., Guo, H., & Zhang, J. (2025) · PLoS ONE · doi:10.1371/journal.pone.0317820 · Cited by 54
Ferroptosis and oxidative stress in endometriosis: A systematic review of the literature
Ni, C., & Li, D. (2024) · Medicine · doi:10.1097/md.0000000000037421 · Cited by 54
“[3] No definitive treatment exists for EMT, which as an estrogen-dependent disease, [4] can reduce pain and slow disease progression by decreasing estrogen production and suppressing ovulation.”
BackgroundEndometriosis: An Immunologist’s Perspective
Garmendia, J. V., Sanctis, C. V. D., Hajdúch, M., & Sanctis, J. B. D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115193 · Cited by 51
“The most relevant miRNA-detected changes in plasma and serum are (1) increased miRNA 122, 199a, 125 b-5p, 150-5p, 342-3p, and 451a, and (2) decreased miRNA Let-7b, Let-7d, Let-7f, 17-5p, 20c, 20a-5p, and 3613-5p [67–71].”
Infertility workup: identifying endometriosis
Pirtea, P., Vulliémoz, N. R., de Ziegler, D., & Ayoubi, J. M. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.03.015 · Cited by 53
An Estrogen–NK Cells Regulatory Axis in Endometriosis, Related Infertility, and Miscarriage
Yang, S., Wang, H., Li, D., & Li, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063362 · Cited by 52
Li, X., Hou, M., Zhang, F., Ji, Z., Cai, Y., & Shi, Y. (2025) · Environmental Science & Technology · doi:10.1021/acs.est.4c08701 · Cited by 52
Endometriosis caused by retrograde menstruation: Now demonstrated by DNA evidence
Bulun, S. E. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.07.012 · Cited by 46
Self-citationHuang, L., Shi, L., Li, M., Yin, X., & Ji, X. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5513 · Cited by 52
Metabolomics for Diagnosis and Prognosis of Uterine Diseases? A Systematic Review
Tokarz, J., Adamski, J., & Rižner, T. L. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10040294 · Cited by 51
Pattern-recognition receptors in endometriosis: A narrative review
Guo, B., Chen, J. H., Zhang, J. H., Fang, Y., Liu, X. J., Zhang, J., Zhu, H. Q., & Zhan, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1161606 · Cited by 49
The Promises of Natural Killer Cell Therapy in Endometriosis
Evert, J. S. H., Paap, R., Nap, A. W., & Molen, R. G. V. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105539 · Cited by 46
The Role of Dietary Fats in the Development and Treatment of Endometriosis
Marcinkowska, A., & Górnicka, M. (2023) · Life · doi:10.3390/life13030654 · Cited by 48
New Insights into Genetics of Endometriosis—A Comprehensive Literature Review
Chiorean, D. M., Mitranovici, M.-I., Toru, H. S., Cotoi, T. C., Tomuț, A. N., Turdean, S. G., & Cotoi, O. S. (2023) · Diagnostics · doi:10.3390/diagnostics13132265 · Cited by 50
Robin, C., Uk, A., Decanter, C., Béhal, H., Collinet, P., Rubod, C., Barbotin, A., & Robin, G. (2021) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-021-00798-x · Cited by 46
Metadata
- Authors
- Bulun, S. E., Yilmaz, B. D., Sison, C., Miyazaki, K., Bernardi, L., Liu, S., Kohlmeier, A., Yin, P., Milad, M., & Wei, J.
- Affiliations
- Northwestern University (US)
- Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
- Corresponding author
- Bulun, Serdar E
- ORCID
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2019-04-17
- Volume
- 40
- Issue
- 4
- Pages
- 1048-1079
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC6693056
- OpenAlex
- W4211072069
- Semantic Scholar
- 65040787dce0d5e2c5ea1422c1499c9646f18963
- Cited by
- 844
- References
- 214
- Citations by year
- 2026: 105 · 2025: 163 · 2024: 158 · 2023: 134 · 2022: 121 · 2021: 91 · 2020: 64 · 2019: 8
- FWCI
- 10.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Child Health and Human Development (HD38691)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Keywords
- pelvic endometriosis, chronic pelvic pain, infertility, endometrial mesenchymal stem cells, epigenetic abnormalities, GATA6, steroidogenic factor 1, estrogen receptor beta, progesterone resistance, KRAS mutation, ovarian cancer, ovulation inhibition, cyclooxygenase inhibitors, in vitro fertilization, targeted therapy
- MeSH terms
- Animals, Endometriosis, Endometrium, Female, Humans, Receptors, Progesterone, Uterine Diseases, Stromal Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.